ReviewInsects2026
Beyond Antimicrobial Defense: Insect Antimicrobial Peptides as Neuroimmune Effectors and Insect-Derived Peptide Resources.
Review in Insects, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Insect antimicrobial peptides (AMPs) are classically viewed as terminal effectors of innate immunity, but emerging evidence suggests that some can also shape defined neural states. In this Review, we argue that insect systems provide a powerful framework for resolving immune-brain communication at the level of individual peptide effectors, because genetically tractable innate-immune pathways allow pathway activation to be distinguished from peptide-specific effector function. Rather than surveying AMP families exhaustively, we focus on representative cases in which peptide identity, source, and timing can be linked to sleep, memory-related plasticity, and responses to acute injury. These studies show that the neural consequences of AMP induction cannot be inferred from pathway activation alone, but require peptide-level analysis of effector identity, cellular context, and exposure logic. This perspective also raises the question of translational potential. At present, direct biomedical development of endogenous insect AMPs in neural contexts remains limited, whereas more tangible applied interest has centered on insect venom peptides that share AMP-like physicochemical features. We therefore discuss insect venoms separately from endogenous AMP physiology. Venom peptides are not physiological equivalents of endogenous insect AMPs, but represent evolutionarily diversified AMP-like templates for scaffold discovery, mechanistic probing, and therapeutic engineering. Together, this review develops a peptide-level perspective on insect neuroimmune biology while highlighting insect venoms as a valuable, but highly constrained, source of templates for biomedical discovery.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.